|

Dalpiciclib 100mg Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • West China Hospital1
  • Fujian Cancer Hospital1

Indications

  • Cancer2
  • Endocrine Breast Diseases1
  • Dalpiciclib1
  • CDK4/6 Inhibitor1
  • HR+/HER2- Breast Cancer1

Other2 trials

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Phase 2
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.